Gérald Lossaint

566 total citations
8 papers, 404 citations indexed

About

Gérald Lossaint is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Gérald Lossaint has authored 8 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Gérald Lossaint's work include DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (3 papers). Gérald Lossaint is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Microtubule and mitosis dynamics (3 papers). Gérald Lossaint collaborates with scholars based in France, Switzerland and Croatia. Gérald Lossaint's co-authors include Vjekoslav Dulić, Daniel Fisher, Kerstin Gari, Angelos Constantinou, Nicole Bec, Marion Larroque, Christian Larroque, Chantal Décaillet, Cyril Ribeyre and Virginie Georget and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and Oncogene.

In The Last Decade

Gérald Lossaint

8 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gérald Lossaint France	7	332	143	72	69	40	8	404
Steven S. Foster United Kingdom	8	503 1.5×	132 0.9×	54 0.8×	41 0.6×	41 1.0×	8	554
Justin Moser United States	7	271 0.8×	153 1.1×	43 0.6×	99 1.4×	32 0.8×	9	439
Brittany C. Lipchick United States	9	380 1.1×	100 0.7×	65 0.9×	52 0.8×	17 0.4×	12	500
Jason A. Lehman United States	13	317 1.0×	135 0.9×	45 0.6×	52 0.8×	23 0.6×	18	427
R. Kulikov Germany	6	463 1.4×	314 2.2×	83 1.2×	71 1.0×	28 0.7×	8	534
Xiangzi Han United States	14	361 1.1×	100 0.7×	71 1.0×	91 1.3×	12 0.3×	15	436
Anil Narasimha United States	3	316 1.0×	191 1.3×	61 0.8×	75 1.1×	15 0.4×	3	460
Tovah A. Day United States	12	392 1.2×	203 1.4×	122 1.7×	56 0.8×	14 0.3×	18	477
Chun‐Hui Su United States	8	325 1.0×	189 1.3×	86 1.2×	110 1.6×	11 0.3×	9	411

Countries citing papers authored by Gérald Lossaint

Since Specialization

Citations

This map shows the geographic impact of Gérald Lossaint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Lossaint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Lossaint more than expected).

Fields of papers citing papers by Gérald Lossaint

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Lossaint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Lossaint. The network helps show where Gérald Lossaint may publish in the future.

Co-authorship network of co-authors of Gérald Lossaint

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Lossaint. A scholar is included among the top collaborators of Gérald Lossaint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Lossaint. Gérald Lossaint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Leenhardt, Fanny, Frédéric Fiteni, Séverine Guiu, et al.. (2022). Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug–Drug Interactions Are the Usual Suspects. Pharmaceutics. 14(4). 841–841. 9 indexed citations

Lossaint, Gérald, Véronique Gire, Karim Mrouj, et al.. (2022). Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest. Journal of Cell Science. 135(8). 26 indexed citations

Lunardi, T., et al.. (2021). The human telomeric proteome during telomere replication. Nucleic Acids Research. 49(21). 12119–12135. 25 indexed citations

Leenhardt, Fanny, Séverine Guiu, Stéphane Pouderoux, et al.. (2021). Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug–drug interactions with oral targeted therapy. Cancer Chemotherapy and Pharmacology. 88(4). 723–729. 5 indexed citations

Lossaint, Gérald, et al.. (2017). Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage. Scientific Reports. 7(1). 13429–13429. 63 indexed citations

Lossaint, Gérald, Marion Larroque, Cyril Ribeyre, et al.. (2013). FANCD2 Binds MCM Proteins and Controls Replisome Function upon Activation of S Phase Checkpoint Signaling. Molecular Cell. 51(5). 678–690. 187 indexed citations

Lossaint, Gérald, Emilie Besnard, Daniel Fisher, Jacques Piette, & Vjekoslav Dulić. (2011). Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene. 30(41). 4261–4274. 62 indexed citations

Chassot, Anne‐Amandine, Gérald Lossaint, Laurent Turchi, et al.. (2008). Confluence-induced cell cycle exit involves pre-mitotic CDK inhibition by p27Kip1 and cyclin D1 downregulation. Cell Cycle. 7(13). 2038–2046. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact